03/08/2019 /
Affected girls and women should be carefully monitored for later?onset psychiatric disorders, researchers suggest.
03/07/2019 /
Discover the latest about what’s happening at CURE and in our community in the March 2019 CURE Update from Chief Scientific Officer, Laura Lubbers!
03/07/2019 /
The Violet Study is intended to support the regulatory filings for approval of ganaxolone in this underserved and refractory patient population.
03/06/2019 /
Children achieving drug-free diet therapy were more likely to be younger, have fewer antiseizure drugs at ketogenic diet onset, have Glut1 deficiency or epilepsy with myoclonic-atonic seizures, but were less likely to have Lennox-Gastaut syndrome or a gastrostomy tube.
03/05/2019 /
Patients with epilepsy who respond to eslicarbazepine acetate (ESL), have a seizure frequency reduction (SFR) of greater than or equal to 75%, and are at the lower SFR threshold of greater than or equal to 50% have higher health-related quality of life (QoL) compared with nonresponders to ESL.
03/05/2019 /
Study designs allowing for long-term comparative observations would be of great value, but are hindered by the inherent nature of a long-term [surgical] control group and the bias associated with open-label trials.
03/05/2019 /
Based on aggregated clinical data analytics, the project will provide insights into disease progression and responses to treatment.
03/04/2019 /
This webinar discusses how epilepsy patients, their families, and pediatric neurologists can develop a plan to prepare for the transition of care.
03/04/2019 /
Researchers find that perampanel increases assessment scores indicative of aggression as well as depression.
